Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

New agents for CNS disorders claimed by HHS

Dec. 30, 1996

Beiersdorf-Lilly claims angiotensin II blockers

Dec. 30, 1996

Otsuka describes new analgesics

Dec. 24, 1996

Natural antineoplastic agents described by Fujisawa

Dec. 24, 1996

Bin1 described by Wistar Institute for cancer Rx and Dx

Dec. 24, 1996

Connaught describes potential acellular pertussis vaccines

Dec. 24, 1996

Neuroprotective polypeptide reported by Amgen

Dec. 24, 1996

Fujisawa discloses antiplatelet agents

Dec. 24, 1996

Agents for urinary incontinence reported by Dainippon

Dec. 23, 1996

LHRH antagonists under study at Takeda

Dec. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...